Under a business collaboration signed between the two companies, Batavia Bioservices will get access to simulated moving bed (SMB) purification technology as well as infrastructure, knowledge and experience in microbial process and product development.
The companies will establish joint marketing efforts whereby Xendo BV will provide engineering, regulatory and clinical support services and Batavia Bioservices will provide process development and analytical services.
Xendo CEO André van de Sande said by combining forces both companies are better positioned to service customers and this helps the company, both in the Netherlands and international, to further expand.